a b s t r a c t
Roughly 26-32% of U. S. veterans who served in the 1991 Persian Gulf War report suffering from chronic health problems. Memory complaints are regularly reported by ill Gulf War veterans (GWV), but limited data verify their complaints. This study investigated episodic memory and brain function in a nationally representative sample of GWV, using a face-name memory task and functional magnetic resonance imaging during encoding. A syndrome classification system was used to subdivide ill GWV into the three major Gulf War Illness syndrome types, "impaired cognition" (GWV-1), "confusion ataxia" (GWV-2), and "central pain" (GWV-3). Memory and brain function of ill GWV were contrasted to deployed and nondeployed well GWV controls (GWV-C). Ill GWV exhibited impaired memory function relative to GWV-C but the patterns of functional brain differences varied. Brain activation differentiated the GWV-C from the ill GWV. The different syndrome types also differed from one another in several brain regions. Additionally, the current study was the first to observe differences in brain function between deployed and nondeployed GWV-C. These results provide (1) evidence of memory impairment in ill GWV and differentiate the syndrome types at a functional neurobiological level, and (2) the role of deployment in the war on brain function.
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Introduction
Of the 697,000 U.S. military personnel who served in operations Desert Shield and Desert Storm in the 1991 Persian Gulf War, 26-32% report suffering from chronic health problems, including muscle and joint pain, chronic fatigue, attention problems, memory and other cognitive deficits, sleep disorders, and headaches. The incidence of these self-reported symptoms is greater among Gulf War veterans (GWV) than control groups (Centers for Disease Control and Prevention, 1995; Fukuda et al., 1998; Haley et al., 1997; Iowa Persian Gulf Study Group, 1997; Steele, 2000) , and selfreports of these symptoms have shown to be linked to structural and functional brain abnormalities (Chao et al., 2010 (Chao et al., , 2011 Hom et al., 1997; White et al., 2001) .
Service-related exposure to neurotoxins (Binns et al., 2008) has been hypothesized to cause the elevated rates of self-reported symptoms and central nervous system abnormalities in Gulf War Illness (GWI). Such neurotoxins include sarin gas and pyridostigmine bromide (PB) tablets, anti-nerve agent pills pharmacologically similar to sarin but that are reversible cholinesterase inhibitors taken as a pretreatment to nerve gas exposure. Recent epidemiological studies, as well as meteorological and intelligence data on chemical weapons fallout from bombing early in the war, have assisted in confirming exposure of GWV to low-level sarin nerve gas (Haley and Tuite, 2013; Tuite and Haley, 2013) . Research conducted in animal models demonstrates that low-dose exposure to sarin and similar organophosphates negatively impacts the central nervous system (Abdel-Rahman et al., 2002 , 2004a , 2004b Henderson et al., 2001; Speed et al., 2012) , and results in behavioral and cognitive abnormalities (Abdel-Rahman et al., 2004b; Gardner et al., 1984; Lamproglou et al., 2009) .
These data suggest that ill GWV are at an elevated risk of experiencing cognitive and behavioral symptoms, but limited research has verified the symptoms they report. Memory impairment, for example, is commonly reported, but ill GWV sometimes do not demonstrate impaired memory performance relative to 
